0001437749-23-033219.txt : 20231130
0001437749-23-033219.hdr.sgml : 20231130
20231130090635
ACCESSION NUMBER: 0001437749-23-033219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231128
FILED AS OF DATE: 20231130
DATE AS OF CHANGE: 20231130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wong Vivien
CENTRAL INDEX KEY: 0001638050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39780
FILM NUMBER: 231454165
MAIL ADDRESS:
STREET 1: 6C CHATEAUX CIRCLE
CITY: SCARSDALE
STATE: NY
ZIP: 10583
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc.
CENTRAL INDEX KEY: 0000922247
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593029743
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6714 NW 16TH STREET, SUITE B
CITY: GAINESVILLE
STATE: FL
ZIP: 32653
BUSINESS PHONE: 386-418-8060
MAIL ADDRESS:
STREET 1: PO BOX 1180
CITY: ALACHUA
STATE: FL
ZIP: 32616-1180
FORMER COMPANY:
FORMER CONFORMED NAME: CTD HOLDINGS INC
DATE OF NAME CHANGE: 20000913
FORMER COMPANY:
FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC
DATE OF NAME CHANGE: 19941012
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-11-28
0000922247
Cyclo Therapeutics, Inc.
CYTH
0001638050
Wong Vivien
C/O CYCLO THERAPEUTICS, INC.
6714 NW 16TH STREET, SUITE B
GAINESVILLE
FL
32653
1
0
Common Stock
2023-11-28
4
A
0
2488
0
A
2488
D
Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34 per share of common stock on November 28, 2023.
/s/ Vivien Wong
2023-11-29